India  

Pfizer enrolls 12 year olds in coronavirus vaccine trials

Video Credit: KTNV Channel 13 Las Vegas - Duration: 00:45s - Published
Pfizer enrolls 12 year olds in coronavirus vaccine trials

Pfizer enrolls 12 year olds in coronavirus vaccine trials

Pfizer is the first company to say it will start enrolling kids as young as 12 in its U.S. coronavirus vaccine trial.

It says it received permission from the FDA this month.

U-S CORONAVIRUS VACCINE TRIAL.IT SAYS IT RECEIVED PERMISSIONFROM THE F-D-A THIS MONTH.THIS IS SOMETHING THE AMERICANACADEMY OF PEDIATRICS HAS BEENPUSHING FOR.DOCTOR YVONNE MALDONADO ISAMONG THE PEDIATRICIANS WHOWROTE TO THE F- D-A IN SUPPORTOF INCLUDING KIDS IN VACCINETRIALS."I THINK THERE ARE PEOPLE WHOWOULD SIGN UP FOR A TRIAL IFTHEY FELT THAT THE DATA ONADULTS WAS WELL DESCRIBED,TRANSPARENT AND THAT SAFETY HADDEFINITELY BEEN ESTABLISHED FORADULTS."GENERALLY VACCINE TRIALS STARTWITH ADULTS ONLY AND SLOWLY ADDYOUNGER AGE GROUPS.PFIZER SAYS IT WILL ENROLL KIDSBASED ON SAFETY DATA IN ITSSTUDIES IN OLDER ADOLESCENTSAND YOUNG ADULTS.IT HASN'T SAID HOW SOON THATWILL HAPPEN.SESAME STREET IS LAUNCHING A




You Might Like


Related videos from verified sources

COVID-19 vaccine trial progressing with help from Valley participants [Video]

COVID-19 vaccine trial progressing with help from Valley participants

America's attention is on Election Day right now, but an equally impactful decision is happening behind the scenes with COVID-19 vaccines.

Credit: ABC15 Arizona     Duration: 02:21Published
AstraZeneca Covid-19 Vaccine Trial Showing Promising Results [Video]

AstraZeneca Covid-19 Vaccine Trial Showing Promising Results

AstraZeneca's Covid-19 vaccine trial has shown promise producing antibodies in adult and elderly patients, a sign that a viable vaccine could be ready by year-end.

Credit: The Street     Duration: 02:03Published
J&J, AstraZeneca resuming trials of vaccines [Video]

J&J, AstraZeneca resuming trials of vaccines

AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week, the companies said on..

Credit: Reuters Studio     Duration: 01:08Published